Human BLOC1S2 Protein

<strong>Human BLOC1S2 Protein </strong>_x000D_ <strong>Catalog number:</strong> B2011613_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 18.5 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 °C_x000D_ <strong>Keywords:</strong> BLOC1S2, BLOCS2 1 protein, BLOCS2-1, BLOS2 protein, BLOCS2-1 protein, BLOCS2 1, RP11-316M21.4 protein_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Shi F, Xue R, Zhou X, Shen P, Wang S, Yang Y. Telitacicept as a BLyS/APRIL dual inhibitor for autoimmune disease Immunopharmacol Immunotoxicol. 2021 Dec;43(6):666-673._x000D_ 2: Dhillon S. Telitacicept: First Approval Drugs. 2021 Sep;81(14):1671-1675._x000D_ 3: Blair HA, Duggan ST. Belimumab: A Review in Systemic Lupus Erythematosus Drugs. 2018 Mar;78(3):355-366._x000D_ 4: Smulski CR, Eibel H. BAFF and BAFF-Receptor in B Cell Selection and Survival Front Immunol. 2018 Oct 8;9:2285._x000D_ 5: Möckel T, Basta F, Weinmann-Menke J, Schwarting A. B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE) Autoimmun Rev. 2021 Feb;20(2):102736._x000D_ 6: Atisha-Fregoso Y, Toz B, Diamond B. Meant to B: B cells as a therapeutic target in systemic lupus erythematosus J Clin Invest. 2021 Jun 15;131(12):e149095._x000D_ 7: Yao X, Ren Y, Zhao Q, Chen X, Jiang J, Liu D, Hu P. Pharmacokinetics analysis based on target-mediated drug distribution for RC18, a novel BLyS/APRIL fusion protein to treat systemic lupus erythematosus and rheumatoid arthritis Eur J Pharm Sci. 2021 Apr 1;159:105704._x000D_ 8: Jin X, Ding C. Belimumab--an anti-BLyS human monoclonal antibody for rheumatoid arthritis Expert Opin Biol Ther. 2013 Feb;13(2):315-22._x000D_ 9: Collins CE, Gavin AL, Migone TS, Hilbert DM, Nemazee D, Stohl W. B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels Arthritis Res Ther. 2006;8(1):R6._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/22388102">10: Lyu MA, Cheung LH, Hittelman WN, Liu Y, Marks JW, Cho MJ, Rosenblum MG. Bax345/BLyS: a novel, completely human fusion protein targeting malignant B cells and delivering a unique mitochondrial toxin Cancer Lett. 2012 Sep 28;322(2):159-68. </a>_x000D_ _x000D_ <strong>Products Related to Human BLOC1S2 Protein can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>